• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. LVIS D; INTRALUMINAL DEVICES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. LVIS D; INTRALUMINAL DEVICES Back to Search Results
Model Number 212525-CAS-D-CN
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/26/2022
Event Type  Injury  
Manufacturer Narrative
A search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.The device remains implanted in the patient and procedure images were not provided; therefore, the alleged product issue cannot be confirmed.
 
Event Description
It was reported during treatment, after the stent was deployed, the doctor found that the guide wire of the stent was broken in the blood vessel when withdrawing the guide wire at the front of the stent.Then the doctor took out the guide wire and used the embolectomy stent.There was no reported harm or injury to the patient.
 
Manufacturer Narrative
Additional information / b5: additional information with images received on 2/02/2023.The provided information indicated, after the stent was deployed, the doctor found that the distal guide wire was fractured in two pieces in the patient.When the stent guide wire was withdrawn, the doctor removed the broken guide wire with the embolic stent.The stent was deployed in the intended location.There was no reported harm or injury to the patient.Visual analysis: the distal end of the pusher appeared perpendicular to the lumen of the microcatheter after being retrieved during the procedure for image 2, 4.The pusher appeared to have been advanced out of the microcatheter for examination and appeared broken at the distal end, along with a detached pusher body coil for image 1, 3.Images 5 and 6 appear to be screenshots of a message chain containing the four images previously referenced.Investigation findings: without the return and physical evaluation of the device, the investigation cannot definitively determine if a condition existed that would have caused or contributed to the reported event.Without imaging, the investigation cannot verify the event occurred as described, nor could the investigation definitively determine the cause of the reported event.Based on a review of the device¿s risk documentation, the reported event did not indicate there were any potential or new manufacturing, design, quality, or other systemic issues, or non-conformances.The complaint code is monitored through the trending process; corrective action is determined, as needed, through this process.Investigations of historic complaint files with similar complaint category coding are recorded in the complaint handling system; without the ability to perform and analysis of the device, this investigation cannot identify with certainty any potential root causes.Batch review: a search for non-conformances associated with this part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.Complaint system review: there are no similar complaints based on the complaint category regarding this batch number from the last two years recorded in the complaint system at the time of this investigation.Ifu review additional information can be found in the ifu, following is taken from the english version potential complications possible complications include but are not limited to the following: hematoma at the puncture site, perforation or dissection of the vessels, intravascular spasm , hemorrhaging , rupture or perforation of aneurysm , coil herniation , device migration , neurologic insufficiencies including stroke and death , ischemia , vascular occlusion , vessel stenosis , incomplete aneurysm occlusion , pseudoaneurysm formation , distal embolization , headache , infection.Reaction to contrast agents including severe allergic reactions and renal failure if lvis device positioning is satisfactory, carefully retract the microcatheter and advance the delivery wire together, to allow the lvis device to deploy across the neck of the aneurysm.Ensure the device proximal radiopaque end markers are approximately 7 mm proximal to the aneurysm neck to ensure an adequate landing zone.The lvis device will expand and total length may foreshorten up to 60 percent from its undeployed length as it exits the microcatheter.Ensure microcatheter is retracted and clear from the proximal flared ends.Note: visualize and refer to the implant radiopaque end markers to maintain adequate implant length, approximately 7 mm on each side of the aneurysm neck or target location to ensure appropriate neck coverage.Warning: do not detach the lvis device if it is not properly positioned in the parent vessel.Observe the delivery wire distal tip to assure it remains within the desired location of the parent vessel.Prior to removing the delivery wire and if necessary, carefully position the microcatheter distal to the lvis device to maintain access through the lvis device.Remove and discard the delivery wire.Warning: the lvis device delivery wire should not be utilized as a guide wire.Do not torque the lvis device.A torque device should not be used.Investigation conclusion: no products were returned for evaluation, but six images of the device post-procedure were provided.The images showed the pusher broken at the distal end and the pusher body coil detached, which is consistent with the alleged product issue.However, without the return and physical evaluation of the device, the investigation is unable to determine if a condition existed that would have caused or contributed to the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LVIS D
Type of Device
INTRALUMINAL DEVICES
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise drive
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise drive
aliso viejo, CA 92656
7142478000
MDR Report Key16240936
MDR Text Key308093242
Report Number2032493-2023-00538
Device Sequence Number1
Product Code QCA
UDI-Device Identifier00812636020013
UDI-Public(01)00812636020013(11)210325(17)240229(10)21032554J
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P170013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2024
Device Model Number212525-CAS-D-CN
Device Lot Number21032554J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/09/2023
Initial Date FDA Received01/25/2023
Supplement Dates Manufacturer Received02/02/2023
Supplement Dates FDA Received03/01/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/25/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age39 YR
Patient SexFemale
-
-